Clinical Trials Directory

Trials / Completed

CompletedNCT03443388

Novel Helmet Design in Patients With Seizures

A Pilot Study of the Safety of a Novel Helmet Design in Patients With Seizures

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Michael A. Gelfand, MD, PhD · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

This is a two-part study that aims to determine the reliability and safety of the use of the Hövding inflatable helmet in seizures, as evidenced by the deployment of the helmet during seizures, and qualitative patient reporting.

Detailed description

Part 1: 4 healthy volunteers will fall from a standing position onto a padded surface to evaluate for consistent helmet deployment from a standing position. Part 2: up to 20 patients with drug resistant epilepsy who do not use existing head-protective devices will be enrolled and assigned to first enter "helmet" or "no helmet" groups. When assigned to the "helmet" group, patients will wear the helmet until deployment during a seizure or up to 3 months. Subjects will complete questionnaires about their seizures including any injuries sustained, post concussive symptom questionnaire, and the circumstances of inflation. Patients will return to site after helmet deployment. While assigned to the "no helmet" group, patients will complete the same questionnaires, except those relating to helmet inflation. We will compare circumstances, injuries, and post concussive scales in seizures resulting in falls occurring while the helmet was worn versus seizures resulting in falls occurring while the helmet was not being worn.

Conditions

Interventions

TypeNameDescription
DEVICEHövding inflatable helmetThe Hövding inflatable helmet is designed for cyclists as a collar with a deployable airbag that inflates when a sensor detects rapid changes in acceleration. The inflated helmet wraps the back and sides of the user's head in inflated nylon fabric which then slowly deflates after deploying.

Timeline

Start date
2017-08-14
Primary completion
2019-12-15
Completion
2020-03-20
First posted
2018-02-23
Last updated
2025-01-09
Results posted
2025-01-09

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03443388. Inclusion in this directory is not an endorsement.